Shana Harrington1, Lori A Michener2, Tiffany Kendig3, Susan Miale4, Steven Z George5. 1. Department of Clinical and Applied Movement Sciences, University of North Florida, Jacksonville, FL; K12 Scholar, Department of Physical Therapy, University of Florida, Gainesville, FL. Electronic address: s.harrington@unf.edu. 2. Department of Physical Therapy, Virginia Commonwealth University - Medical College of Virginia Campus, Richmond, VA. 3. Rehabilitation Medicine Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY. 4. Department of Physical Therapy, School of Health Technology and Management, Stony Brook University, Stony Brook, NY. 5. Department of Physical Therapy, University of Florida, Gainesville, FL.
Abstract
OBJECTIVES: (1) To identify English-language published patient-reported upper extremity outcome measures used in breast cancer research and (2) to examine construct validity and responsiveness in patient-reported upper extremity outcome measures used in breast cancer research. DATA SOURCES: PubMed, Cumulative Index to Nursing and Allied Health Literature, and ProQuest MEDLINE databases were searched up to February 5, 2013. STUDY SELECTION: Studies were included if a patient-reported upper extremity outcome measure was administered, the participants were diagnosed with breast cancer, and the study was published in English. DATA EXTRACTION: A total of 865 articles were screened. Fifty-nine full text articles were assessed for eligibility. A total of 46 articles met the initial eligibility criteria for aim 1. Eleven of these articles reported means and SDs for the outcome scores and included a comparison group analysis for aim 2. DATA SYNTHESIS: Construct validity was evaluated by calculating effect sizes for known-group differences in 6 studies using the Disabilities of Arm, Shoulder and Hand (DASH), University of Pennsylvania Shoulder Score, Shoulder Disability Questionnaire-Dutch, and 10 Questions by Wingate. Responsiveness was analyzed comparing a treatment and control group by calculating the coefficient of responsiveness in 5 studies for the DASH and 10 Questions by Wingate. CONCLUSIONS: Eight different patient-reported upper extremity outcome measures have been reported in the peer-review literature for women with breast cancer; some that were specifically developed for breast cancer survivors (n=3) and others that were not (n=5). Based on the current evidence, we recommend administering the DASH to assess patient-reported upper extremity function in breast cancer survivors because the DASH has the most consistently large effects sizes for construct validity and responsiveness. Future large studies are needed for more definitive recommendations.
OBJECTIVES: (1) To identify English-language published patient-reported upper extremity outcome measures used in breast cancer research and (2) to examine construct validity and responsiveness in patient-reported upper extremity outcome measures used in breast cancer research. DATA SOURCES: PubMed, Cumulative Index to Nursing and Allied Health Literature, and ProQuest MEDLINE databases were searched up to February 5, 2013. STUDY SELECTION: Studies were included if a patient-reported upper extremity outcome measure was administered, the participants were diagnosed with breast cancer, and the study was published in English. DATA EXTRACTION: A total of 865 articles were screened. Fifty-nine full text articles were assessed for eligibility. A total of 46 articles met the initial eligibility criteria for aim 1. Eleven of these articles reported means and SDs for the outcome scores and included a comparison group analysis for aim 2. DATA SYNTHESIS: Construct validity was evaluated by calculating effect sizes for known-group differences in 6 studies using the Disabilities of Arm, Shoulder and Hand (DASH), University of Pennsylvania Shoulder Score, Shoulder Disability Questionnaire-Dutch, and 10 Questions by Wingate. Responsiveness was analyzed comparing a treatment and control group by calculating the coefficient of responsiveness in 5 studies for the DASH and 10 Questions by Wingate. CONCLUSIONS: Eight different patient-reported upper extremity outcome measures have been reported in the peer-review literature for women with breast cancer; some that were specifically developed for breast cancer survivors (n=3) and others that were not (n=5). Based on the current evidence, we recommend administering the DASH to assess patient-reported upper extremity function in breast cancer survivors because the DASH has the most consistently large effects sizes for construct validity and responsiveness. Future large studies are needed for more definitive recommendations.
Authors: Louisa G Gordon; Paul Scuffham; Diana Battistutta; Nick Graves; Margaret Tweeddale; Beth Newman Journal: Breast Cancer Res Treat Date: 2005-11 Impact factor: 4.872
Authors: Shana Harrington; Darin Padua; Claudio Battaglini; Lori A Michener; Carol Giuliani; Joseph Myers; Diane Groff Journal: J Cancer Surviv Date: 2011-01-12 Impact factor: 4.442
Authors: Brian G Leggin; Lori A Michener; Michael A Shaffer; Susan K Brenneman; Joseph P Iannotti; Gerald R Williams Journal: J Orthop Sports Phys Ther Date: 2006-03 Impact factor: 4.751
Authors: Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872
Authors: Frank C Sweeney; Wendy Demark-Wahnefried; Kerry S Courneya; Nathalie Sami; Kyuwan Lee; Debu Tripathy; Kimiko Yamada; Thomas A Buchanan; Darcy V Spicer; Leslie Bernstein; Joanne E Mortimer; Christina M Dieli-Conwright Journal: Phys Ther Date: 2019-10-28
Authors: Thais Cristina Siqueira; Simone Pedrozo Frágoas; Andreia Pelegrini; Ana Rosa de Oliveira; Clarissa Medeiros da Luz Journal: Support Care Cancer Date: 2020-08-17 Impact factor: 3.603
Authors: Shana E Harrington; Nicole L Stout; Elizabeth Hile; Mary Insana Fisher; Melissa Eden; Victoria Marchese; Lucinda A Pfalzer Journal: Phys Ther Date: 2020-03-10